Oncolytics Biotech Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Aug '25 Aug 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2016 - 2020
Market Capitalization	141	103	132	131	96	131	Upgrade
Market Cap Growth	-10.33%	-22.52%	0.96%	36.08%	-26.39%	-19.30%	Upgrade
Enterprise Value	127	84	93	99	49	105	Upgrade
Last Close Price	1.40	1.33	1.79	2.22	1.75	3.02	Upgrade
PB Ratio	23.08	17.13	4.80	4.95	2.67	5.29	Upgrade
P/TBV Ratio	23.08	17.13	4.80	4.95	2.67	5.29	Upgrade
Debt / Equity Ratio	0.15	0.18	0.02	0.01	0.02	0.02	Upgrade
Quick Ratio	2.24	2.39	8.24	8.15	15.37	11.56	Upgrade
Current Ratio	2.88	2.82	9.01	9.05	16.69	12.45	Upgrade
Return on Equity (ROE)	-249.28%	-189.05%	-102.66%	-79.34%	-86.45%	-182.63%	Upgrade
Return on Assets (ROA)	-74.56%	-74.11%	-55.46%	-40.44%	-40.88%	-58.93%	Upgrade
Return on Capital (ROIC)	-146.95%	-124.82%	-76.99%	-52.89%	-52.97%	-124.54%	Upgrade
Earnings Yield	-21.64%	-30.93%	-20.98%	-18.95%	-27.32%	-17.20%	Upgrade
FCF Yield	-17.57%	-26.54%	-21.51%	-17.86%	-23.59%	-16.89%	Upgrade
Buyback Yield / Dilution	-11.95%	-13.10%	-16.53%	-8.44%	-32.66%	-82.22%	Upgrade

Updated Mar 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.